1. Aboseif SR, Breza J, Bosch RJLH, Benard F, Stief CG, Stackl W, et al. (1989) Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates. J Urol (Baltimore) 142:403–408
2. Adaikan PG, Ng SC, Chan C, Ratnam SS (1990) Why intracavernous PGE1 for diagnosis and treatment of impotence? Int J Impotence Res 2 [Suppl 2]:325–326
3. Antolin AR, Morales JM, Andres A, Aparicio TF, Gonzales RD, Pamplona M, et al. (1992) Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs. Transplant Proc 24:105–106
4. Bellorofonte C, Ruoppolo M, Dell'Acqua S, Zaatar C, Ferri PM, Yamak R, et al. (1991) Intracavernous drug infusion: considerations on studies performed in the past decade and new findings involving PGE1. Archivio Italiano di Urologia 63:475–479 (in Italian)
5. Bénard F, Lue TF (1990) Self-administration in the pharmacological treatment of impotence. Drugs 39:394–398